Medical Doctor Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

Tiashi Greer

Pain Medicine Memphis, TN Medical Doctor

NPI 1619505930 CMS profile 11692816

55 Humphreys Center Dr, Memphis, TN 38120

Open in the dashboard

General payments

$3,720

42 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tiashi Greer of Memphis, TN is reported in the CMS Open Payments database as having received $3,720 across 42 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 59th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,376 24
2024 General $1,344 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tiashi Greer
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Tiashi Greer were reported at $2,376. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Tiashi Greer Pain Medicine median Middle half National median
2019 $0 $498 $126–$1,682 $163
2020 $0 $284 $80–$910 $114
2021 $0 $399 $112–$1,219 $132
2022 $0 $455 $137–$1,484 $149
2023 $0 $484 $128–$1,495 $160
2024 $1,344 $498 $131–$1,540 $164
2025 $2,376 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Abbott Laboratories $1,975 14 payments
  2. Medtronic, Inc. $1,322 17 payments
  3. Saluda Medical Americas, Inc. $212 3 payments
  4. Salix Pharmaceuticals, a division of Bausch Health US, LLC $49 2 payments
  5. MML US, Inc. $42 1 payment
  6. Vertex Pharmaceuticals Incorporated $41 2 payments
  7. AbbVie, Inc. $29 1 payment
  8. Avanos Medical $27 1 payment
  9. Averitas Pharma Inc. $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Food and Beverage $2,101 32 payments
  2. Travel and Lodging $1,618 10 payments
Products named General payments · program years 2024–2025
  1. INTELLIS ADAPTIVESTIM $1,237 15 payments
  2. PROCLAIM Structural Heart $942 3 payments
  3. PROCLAIM Structural Heart $496 4 payments
  4. ETERNA $300 5 payments
  5. DURATA $237 2 payments
  6. Evoke $212 3 payments
  7. KYPHON EXPRESS II KYPHOPAK TRAY $85 2 payments
  8. RELISTOR Gastroenterology $49 2 payments
  9. RELISTOR Gastroenterology $49 2 payments
  10. ReActiv8 $42 1 payment
  11. Other $119 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

42 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record